New Omicron Booster tested only on mice

Justin Sullivan/Getty Images
Like Love Haha Wow Sad Angry

The U.S. Food and Drug Administration is using a controversial strategy to evaluate the next generation of COVID-19 boosters.

The approach is stirring debate as the agency works to make new, hopefully improved, boosters available in September to help prevent severe disease and save lives in the fall and winter.

For the first time, the FDA is planning to base its decision about whether to authorize new boosters on studies involving mice instead of humans.

“For the FDA to rely on mouse data is just bizarre, in my opinion,” says John Moore, an immunologist at Weill Cornell Medicine in New York. “Mouse data are not going to be predictive in any way of what you would see in humans.”


What Are Your Thoughts?


Chuck comes from a lineage of journalism. He has written for some of the webs most popular news sites. He enjoys spending time outdoors, bull riding, and collecting old vinyl records. Roll Tide!